| |
Metro
|
Rural RUCC 4–6
|
P value (comparison to metro)
|
Rural RUCC 7–9
|
P value (comparison to metro)
|
P value (compare rural RUCC 4-6to rural RUCC 7–9)
|
|---|
|
N = 175,184
|
N = 19,346
|
N = 2968
|
|---|
|
Mean age (years)
|
66.0
|
66.5
|
< 0.001
|
67.0
|
< 0.001
|
0.05
|
|
Female
|
51.2%
|
48.2%
|
< 0.001
|
47.4%
|
51.2%
|
0.43
|
|
White
|
86.7%
|
98.3%
|
< 0.001
|
98.0%
|
86.7%
|
0.24
|
|
Non-white
|
12.4%
|
1.4%
|
< 0.001
|
1.3%
|
12.4%
|
0.74
|
|
Hispanic
|
1.72%
|
0.35%
|
< 0.001
|
0.40%
|
< 0.001
|
0.62
|
|
Uninsured
|
1.0%
|
1.1%
|
0.40
|
1.0%
|
0.96
|
0.71
|
|
Private insurance
|
36.8%
|
32.0%
|
< 0.001
|
29.3%
|
< 0.001
|
0.00
|
|
Medicaid
|
5.7%
|
5.6%
|
0.43
|
5.2%
|
0.21
|
0.37
|
|
Medicare
|
44.7%
|
49.5%
|
< 0.001
|
54.4%
|
< 0.001
|
< 0.001
|
|
Dual-eligible
|
2.9%
|
4.2%
|
< 0.001
|
5.6%
|
< 0.001
|
< 0.001
|
|
Other insurance
|
8.9%
|
7.6%
|
< 0.001
|
4.5%
|
< 0.001
|
< 0.001
|
|
Travel time to nearest facility (minutes)
|
19.3
|
31.8
|
< 0.001
|
42.7
|
< 0.001
|
< 0.001
|
|
Mean number of facilities visited
|
1.0
|
1.0
|
0.03
|
1.0
|
0.02
|
0.11
|
|
US News hospital score
|
26.9
|
17.3
|
< 0.001
|
15.3
|
< 0.001
|
< 0.001
|
|
US News hospital score missing
|
26.9%
|
45.5%
|
< 0.001
|
56.6%
|
< 0.001
|
< 0.001
|
|
Volume of cases 2010–2014 at facility attended (in 100’s)
|
49.5
|
44.6
|
< 0.001
|
43.3
|
< 0.001
|
0.20
|
|
Lung/bronchus
|
17.9%
|
17.6%
|
0.47
|
16.5%
|
0.06
|
0.14
|
|
Colorectal
|
12.5%
|
13.8%
|
< 0.001
|
14.1%
|
0.01
|
0.67
|
|
Prostate
|
13.8%
|
13.8%
|
0.96
|
16.9%
|
< 0.001
|
< 0.001
|
|
Female breast
|
17.8%
|
15.8%
|
< 0.001
|
16.6%
|
0.08
|
0.25
|
|
Cervical/uterine
|
0.9%
|
0.8%
|
0.56
|
0.5%
|
0.02
|
0.04
|
|
Oral/pharyngeal
|
3.0%
|
3.2%
|
0.13
|
2.8%
|
0.68
|
0.34
|
|
Ovarian
|
1.9%
|
1.8%
|
0.59
|
1.7%
|
0.56
|
0.73
|
|
Thyroid
|
5.5%
|
5.3%
|
0.31
|
5.5%
|
0.98
|
0.68
|
|
Melanoma
|
5.7%
|
6.0%
|
0.07
|
7.0%
|
0.00
|
0.03
|
|
Other urological
|
9.5%
|
10.5%
|
< 0.001
|
9.5%
|
0.93
|
0.08
|
|
Other digestive
|
11.6%
|
11.3%
|
0.28
|
8.8%
|
< 0.001
|
< 0.001
|
|
Local
|
52.1%
|
52.1%
|
0.90
|
55.1%
|
0.00
|
0.00
|
|
Regional
|
24.1%
|
23.9%
|
0.66
|
21.2%
|
< 0.001
|
0.00
|
|
Distant
|
21.5%
|
21.5%
|
0.96
|
20.2%
|
0.09
|
0.11
|
|
Unknown stage
|
2.2%
|
2.5%
|
0.06
|
3.5%
|
< 0.001
|
< 0.001
|
|
Chemotherapy
|
26.0%
|
24.8%
|
< 0.001
|
21.0%
|
< 0.001
|
< 0.001
|
|
Radiation therapy
|
25.4%
|
23.5%
|
< 0.001
|
23.9%
|
0.06
|
0.64
|
|
Surgery
|
66.5%
|
67.7%
|
< 0.001
|
69.6%
|
< 0.001
|
0.04
|
|
Immunotherapy
|
0.9%
|
0.7%
|
< 0.001
|
1.0%
|
0.69
|
0.03
|
|
Hormone therapy
|
15.7%
|
14.5%
|
< 0.001
|
16.8%
|
0.10
|
< 0.001
|
- aFor test of differences between rural-urban category of residence, P value is for t-test for continuous variables and Chi-squared test for categorical variables
